The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,325.00
Bid: 2,300.00
Ask: 2,350.00
Change: 20.00 (0.88%)
Spread: 50.00 (2.174%)
Open: 2,275.00
High: 2,300.00
Low: 2,280.00
Prev. Close: 2,280.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options & Long Term Incentive Plan Awards

5 Sep 2018 12:20

RNS Number : 8726Z
Craneware plc
05 September 2018
 

 

Craneware plc

("Craneware" or the "Company")

 

Grant of Options

&

Long Term Incentive Plan Awards

 

5 September 2018 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 5 September 2018, share options (the "Options") to acquire ordinary shares of 1p each in the Company ("Shares") were granted to two of the Company's Directors as set out below. The Options were granted pursuant to the terms of the Craneware plc Unapproved Share Option Plan (2016) (the "Option Plan").

 

Director

Aggregate no. of Shares over which Options granted under the Option Plan

Percentage of issued share capital

Keith Neilson (CEO)

5,848

0.02%

Craig Preston (CFO)

4,334

0.02%

 

The above Options have been granted at an exercise price of 2710p per Share (being the closing market price on 4 September 2018). The Options will ordinarily become exercisable from the third anniversary of grant, subject to (i) the satisfaction of certain performance conditions based on the Company's total shareholder return ("TSR") performance relative to the performance achieved by the constituent companies within the FTSE AIM 100 Index and (ii) the Director's continued employment. These performance conditions are measured in three tranches such that one third of the Shares over which the Options subsist will vest based on performance over the three years ending on 30 June 2019, one third based on performance over the three years ending 30 June 2020 and the final third based on performance over the three years to 30 June 2021 - an aggregate five year period. Any tranche (or part thereof) that does not meet the performance criteria will lapse and not be re-tested in later years.

 

The Company further announces that on 5 September 2018, under the terms of the Craneware plc Long Term Incentive Plan (2016) ("LTIP"), a conditional award of Shares was granted to two Directors of the Company as follows:

 

Director

No. of Shares over which a conditional share award was granted

Percentage of issued share capital

Keith Neilson (CEO)

5,848

0.02%

Craig Preston (CFO)

4,334

0.02%

 

There was no consideration for the grant of the LTIP awards and no consideration will be payable by the award holders to receive the Shares from these LTIP awards, if and to the extent that they vest. The awards will ordinarily vest after three years subject to (i) the satisfaction of TSR performance conditions that are substantively the same as those described above in relation to the Options and (ii) the Director's continued employment.

 

 

 

PDMR notification: Keith Neilson

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Keith Neilson

 

2. Reason for the notification

a) Position / status CEO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of share options under the Craneware plc Unapproved Share Option Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 5,848, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 5,848

ii. Price Price(s) £0

 

f) Date of the transaction 2018-09-05

 

g) Place of the transaction Outside a trading venue

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 5,848, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 5,848

ii. Price Price(s) £0

 

f) Date of the transaction 2018-09-05

 

g) Place of the transaction Outside a trading venue

 

PDMR notification: Craig Preston

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Craig Preston

 

2. Reason for the notification

a) Position / status CFO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of share options under the Craneware plc Unapproved Share Option Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 4,334, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 4,334

ii. Price Price(s) £0

 

f) Date of the transaction 2018-09-05

 

g) Place of the transaction Outside a trading venue

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 4,334, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 4,334

ii. Price Price(s) £0

 

f) Date of the transaction 2018-09-05

 

g) Place of the transaction Outside a trading venue

 

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt (NOMAD & Joint Broker)

Investec Bank (Joint Broker)

Alma (Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)208 004 4217

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Sebastian Lawrence

Henry Reast

Robyn Fisher

Josh Royston

 

 

 

 

 

 

 

 

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSSAFFIFASEFU
Date   Source Headline
28th Aug 20147:00 amRNSBoard Appointment and Acquisition
17th Jul 201410:46 amRNSTransaction in Own Securities, Total Voting Rights
15th Jul 20147:00 amRNSTrading Update
28th Apr 20147:00 amRNSSignificant Contract Win
16th Apr 20145:00 pmRNSBlocklisting Interim Review
11th Apr 201412:05 pmRNSDirector/PDMR Shareholding
4th Apr 20144:27 pmRNSDirector/PDMR Shareholding
2nd Apr 20147:00 amRNSSignificant Contract Wins
31st Mar 20142:29 pmRNSDividend Currency Election
11th Mar 20147:00 amRNSHalf Yearly Report
16th Jan 20147:00 amRNSTrading Update and Notice of Results
22nd Nov 20134:57 pmRNSHolding(s) in Company
15th Nov 20137:00 amRNSDividend Currency Election
12th Nov 20135:52 pmRNSResult of AGM
12th Nov 20137:00 amRNSAGM Statement and Appointment
18th Oct 20131:57 pmRNSPosting of Annual Report, Notice of AGM
30th Sep 20132:20 pmRNSHolding(s) in Company
12th Sep 20136:25 pmRNSDirector/PDMR Shareholding
11th Sep 20134:40 pmRNSDirector/PDMR Shareholding
11th Sep 20138:50 amRNSGrant of Options
10th Sep 20137:00 amRNSFinal Results
12th Jul 20137:00 amRNSNotice of Results
26th Jun 20137:00 amRNSTrading Update
15th Apr 201311:09 amRNSBlocklisting Interim Review
12th Apr 20135:32 pmRNSTotal Voting Rights
18th Mar 20133:30 pmRNSDividend Currency Election
4th Mar 20134:29 pmRNSTotal Voting Rights
27th Feb 201312:29 pmRNSDirector/PDMR Shareholding
26th Feb 20137:00 amRNSHalf Yearly Report
15th Feb 201312:00 pmRNSHolding(s) in Company
21st Jan 20137:00 amRNSTrading Update
30th Nov 201212:41 pmRNSHolding(s) in Company
9th Nov 20127:00 amRNSDividend Currency Election
8th Nov 201211:45 amRNSResult of AGM
8th Nov 20128:00 amRNSAGM Statement
19th Oct 201212:54 pmRNSBlocklisting Interim Review
10th Oct 20125:32 pmRNSPosting of Annual Report & Notice of AGM
24th Sep 20125:22 pmRNSGrant of Options
19th Sep 20125:53 pmRNSHolding(s) in Company
17th Sep 201211:38 amRNSDirector/PDMR Shareholding
6th Sep 201211:35 amRNSDirector/PDMR Shareholding
4th Sep 20127:00 amRNSFinal Results
29th Aug 20127:00 amRNSesMD Certification
15th Aug 20127:00 amRNSNotice of Results
2nd Aug 20122:58 pmRNSHolding(s) in Company
2nd Jul 20127:00 amRNSTrading Update
15th Jun 201210:57 amRNSTotal Voting Rights
31st May 201212:32 pmRNSHolding(s) in Company
29th May 20121:03 pmRNSHolding(s) in Company
28th May 20124:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.